Editorial: Warfarin reversal: Schism between clinical practice and published guidelines

Transfusion

Volumn 53, Issue 3, 2013, Pages 476-479

  Shah, Neil ^a   Sarode, Ravi ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN ETEXILATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIVAROXABAN; VITAMIN K GROUP; WARFARIN;

ANAPHYLAXIS; BLEEDING; BLOOD TRANSFUSION; CLINICAL PRACTICE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; PRACTICE GUIDELINE; REVIEW; THROMBOEMBOLISM; DRUG ANTAGONISM; FEMALE; MALE; NOTE;

FEMALE; HUMANS; MALE; VITAMIN K; WARFARIN;

EID: 84874845026     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12104     Document Type: Review

References (21)

1. Garcia D, Ageno W, Bussey H, Eikelboom J, Margaglione M, Marongiu F, Moia M, Palareti G, Pengo V, Poli D, Schulman S, Witt D, Wittkowksy A, Crowther M,. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 1: prevention. Am J Hematol 2009; 84: 579-583.
2. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G,; American College of Chest Physicians. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e44S-88S.
3. Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, Kitchen S, Makris M,; British Committee for Standards in Haematology. Guidelines on oral anticoagulation with warfarin-4th edition. Br J Haematol 2011; 154: 311-324.
4. Watson HG, Baglin T, Laidlaw SL, Makris M, Preston FE,. A comparison of the efficacy and rate of response to oral and intravenous vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol 2001; 115: 145-149.
5. Crowther MA, Douketis JD, Schnurr T, Steidl L, Mera V, Ultori C, Venco A, Ageno W,. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. Ann Intern Med 2002; 137: 251-254.
6. Whitling AM, Bussey HI, Lyons RM,. Comparing different routes and doses of phytonadione for reversing excessive anticoagulation. Arch Intern Med 1998; 158: 2136-2140.
7. Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D,. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Arch Intern Med 2003; 163: 2469-2473.
8. Burbury KL, Milner A, Snooks B, Jupe D, Westerman DA,. Short-term warfarin reversal for elective surgery-using low-dose intravenous vitamin K: safe, reliable and convenient. Br J Haematol 2011; 154: 626-634.
9. Crowther MA, Wilson S,. Vitamin K for the treatment of asymptomatic coagulopathy associated with oral anticoagulant therapy. J Thromb Thrombolysis 2003; 16: 69-72.
10. 1): a 5-year retrospective review. Ann Allergy, Asthma Immunol 2002; 89: 400-406.
11. Fiore LD, Scola MA, Cantillon CE, Brophy MT,. Anaphylactoid reactions to vitamin K. J Thromb Thrombolysis 2001; 11: 175-183.
12. Goodnough LT, Shander A,. How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. Blood 2011; 117: 6091-6099.
13. Hylek EM, Singer DE,. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994; 120: 897-902.
14. Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston MA, Sarode R,. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion 2009; 49: 1171-1177.
15. Pandit TN, Sarode R,. Blood component support in acquired coagulopathic conditions: is there a method to the madness? Am J Hematol 2012; 87: S56-S62.
16. Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C,. Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. Transfusion 2010; 50: 487-492.
17. Jatoi A, Lennon C, O'Brien M, Booth SL, Sadowski J, Mason JB,. Protein-calorie malnutrition does not predict subtle vitamin K depletion in hospitalized patients. Eur J Clin Nutr 1998; 52: 934-937.
18. Pereira SP, Rowbotham D, Fitt S, Shearer MJ, Wendon J, Williams R,. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. J Hepatol 2005; 42: 365-370.
19. Pineo GF, Gallus AS, Hirsh J,. Unexpected vitamin K deficiency in hospitalized patients. Can Med Assoc J 1973; 109: 880-883.
20. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L,; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
21. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM,; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.